Skip to main content
Hit enter to search or ESC to close
Close Search
Action Santé Mondiale
  • Home
  • Identity
  • Causes
    • Fight against pandemics
    • Women and Child’s Health
    • Funding and quality of aid
    • Research and Development
    • All our causes
  • Opinions
  • Resources
  • Contact
  • French
  Research and Development

Promoting transparent and needs-driven
EU R&D policies

What’s at stake?

The European Union is a key actor in the fight against poverty-related and neglected diseases, such as HIV/Aids, tuberculosis and malaria. Financing Research & Development (R&D) helps save lives, fight against epidemics, prevent future health crises, reach the SDGs, contribute to the creation of qualified jobs and stimulate science in the EU.

The EU Framework Programme for Research and Innovation,  « Horizon 2020 » (2014-2020), with a budget of €77 billion will soon be renewed under « Horizon Europe » (2021-2027). The European Commission pursues two objectives with this programme : improving economic growth and creating jobs and addressing major societal challenges.

EU’s investments have resulted in new treatments, accelerated research into new vaccines for many diseases and financed ambitious global health research. However, key issues remain : despite massive EU investments, there is a lack of commercial incentives for investments into R&D for many diseases such as malaria and TB or resistance to antimicrobials. There are no conditionalities attached to EU research funds in terms of financial or geographic access to end-products or transparency of R&D costs. Our current biomedical R&D system, while heavily funded by public money evolved towards a market-oriented model maximising private return on public investments. As a result, the current system does not effectively respond to public health needs with States unable to further the right to health.

Our asks:

Health R&D should prioritise public health and patients’ needs, guarantee quality of innovative medicines and fight against inequalities at the European and the global level. We’re asking for:

  • The health budget under « Horizon Europe » to be increased in order to give the EU the means to repond to the unprecedented COVID19 crisis and reach SDG3. Not less than 10% of the « Horizon Europe » budget should be allocated to health.
  • Strategic priorities of « Horizon Europe » to be defined together with civil society, according to public health needs and taking into account existing financing gaps for poverty-related and neglected diseases.
  • The Innovative Medicines Initiative (IMI) to be reformed towards more transparency and inclusiveness.
  • Bilateral trade agreements to remove « TRIPS-plus » regulations (Trade-Related Aspects of Intellectual Property Rights) which help further monopolies and refrain States from putting conditionalities to public financing.
Share Tweet Share

Global Health Advocates is a French NGO which mission is to carry out political advocacy in France and with the EU institutions to ensure policies and resources are effectively addressing health inequalities.

Adresses

Paris Office

Global Health Advocates France
176 rue du Temple
75 003 Paris

Advocacy team
Tel : +33 9 81 85 33 16
Finance & administration
info@ghadvocates.org

Brussels Office

Mundo J
Rue de l’Industrie 10
1000, Brussels

Advocacy Team
Tel: +32 (0) 2 669 42 56

Réseaux sociaux

GHA France Follow

Action Santé Mondiale/Global Health Advocates ONG de plaidoyer qui lutte pour un accès à la #santé pour tou·te·s auprès des institutions FR & UE @GHABrussels

GHAFrance
ghafrance GHA France @ghafrance ·
8 Mar

En cette journée des droits des femmes #IWD2023 ♀, @GHAFrance participe à la présentation des priorités de la diplomatie #féministe de la France 🇫🇷 par @MinColonna. On attend avec impatience le lancement de la nouvelle stratégie internationale de la France en matière de #DSSR ⚕️

Reply on Twitter 1633498972403777538 Retweet on Twitter 1633498972403777538 4 Like on Twitter 1633498972403777538 8 Twitter 1633498972403777538

GHA EU Follow

Global Health Advocates / Action Santé Mondiale Advocacy NGO that fights for #HealthforAll at the #EU level & in France @GHAFrance

GHABrussels
ghabrussels GHA EU @ghabrussels ·
9 Mar

🤝Alongside 19 partner organisations, @GHABrussels call on the @EU_Commission to publish the proposed revision of the EU 🇪🇺 #pharma legislation in March. We cannot have more delays!
See our joint letter 🔗https://www.ghadvocates.eu/joint-letter-requesting-publication-proposed-revision-eu-pharmaceutical-legislation/

Reply on Twitter 1633877856446210049 Retweet on Twitter 1633877856446210049 Like on Twitter 1633877856446210049 2 Twitter 1633877856446210049

Contact us

    © Action Santé Mondiale 2020 - Tous droits réservés - Mentions légales

    Close Menu
    • Home
    • Identity
    • Causes
      • Fight against pandemics
      • Women and Child’s Health
      • Funding and quality of aid
      • Research and Development
      • All our causes
    • Opinions
    • Resources
    • Contact
    • French